Baolingbao Biology Co.,Ltd. (SHE:002286)
8.33
-0.11 (-1.30%)
Sep 2, 2026, 1:30 PM CST
Baolingbao Biology Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,848 | 2,751 | 2,402 | 2,524 | 2,713 | 2,765 |
Revenue Growth | 8.89% | 14.54% | -4.84% | -6.96% | -1.89% | 34.58% |
Gross Profit Gross Profit Growth | 396.22 | 361.32 | 278.47 | 197.52 | 308.4 | 368.24 |
Operating Income Operating Income Growth | 171.8 | 172.45 | 143.7 | 59.78 | 156.58 | 213.03 |
Net Income Net Income Growth | 140.28 | 150.63 | 111.16 | 53.97 | 133.17 | 201.58 |
Earnings Per Share EPS Growth | 0.38 | 0.41 | 0.30 | 0.15 | 0.36 | 0.54 |
EPS Growth | 5.51% | 36.67% | 100.00% | -58.33% | -33.33% | 285.71% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
China China Growth | 2,032 | 1,790 | 1,784 | 1,862 | 1,843 |
Foreign Foreign Growth | 719.52 | 611.53 | 739.45 | 851.14 | 922.46 |
Total Total Growth | 2,751 | 2,402 | 2,524 | 2,713 | 2,765 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 312.8 | 276.78 | 254.95 | 242.74 | 375.95 | 692.11 |
Total Debt Total Debt Growth | 177.35 | 126.54 | 282.81 | 304.13 | 516.6 | 411.88 |
Net Cash (Debt) Net Cash Growth | 135.45 | 150.24 | -27.86 | -61.39 | -140.65 | 280.23 |
Net Cash Growth | - | - | - | - | - | 17.19% |
Net Cash Per Share Net Cash Per Share Growth | 0.37 | 0.41 | -0.08 | -0.17 | -0.38 | 0.75 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 354.81 | 259.36 | 248.72 | 282.28 | 30.82 | 206.27 |
Capital Expenditures CapEx Growth | -242.84 | -189.3 | -189.93 | -152.23 | -254.55 | -92.85 |
Free Cash Flow Free Cash Flow Growth | 111.96 | 70.07 | 58.79 | 130.05 | -223.72 | 113.42 |
Free Cash Flow Growth | 92.34% | 19.18% | -54.79% | - | - | -57.45% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 13.91% | 13.13% | 11.59% | 7.83% | 11.37% | 13.32% |
Operating Margin | 6.03% | 6.27% | 5.98% | 2.37% | 5.77% | 7.70% |
Pretax Margin | 5.90% | 6.46% | 5.46% | 2.58% | 5.78% | 8.56% |
Profit Margin | 4.93% | 5.47% | 4.63% | 2.14% | 4.91% | 7.29% |
FCF Margin | 3.93% | 2.55% | 2.45% | 5.15% | -8.25% | 4.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.120 | 0.120 | 0.095 | 0.080 | 0.080 | 0.060 |
Dividend Per Share Growth | 26.32% | 26.32% | 18.75% | 0% | 33.33% | 0% |
Dividend Yield | 1.50% | 1.36% | 1.31% | 1.02% | 0.92% | 0.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 22.21 | 22.59 | 24.55 | 55.79 | 25.38 | 24.94 |
Forward PE | 15.92 | 16.71 | 10.69 | 10.69 | 10.69 | 22.67 |
P/FCF Ratio | 28.69 | 48.56 | 46.42 | 23.15 | - | 44.33 |
PS Ratio | 1.13 | 1.24 | 1.14 | 1.19 | 1.25 | 1.82 |